Fig. 2.
Difference between the observed and expected mortality for ECB or FAW on diets containing mixtures of Cry1Ab + Vip3Aa20 + Cry1F 120 hours after treatment. X refers to the A or B undiluted mixture as described in the Methods section for ECB or FAW, respectively. X/2 to X/16 refers to serial dilutions for each respective mixture.
